Recommendations Developed for Prevention of Pediatric Atopic Dermatitis
Medically reviewed by Drugs.com
via HealthDayTUESDAY, April 14, 2026 -- Recommendations are presented for the prevention and management of pediatric atopic dermatitis (AD) in two guidelines issued by the American Academy of Dermatology and published online April 7 in the Journal of the American Academy of Dermatology.
Robert Sidbury, M.D., M.P.H., from the University of Washington School of Medicine in Seattle, and colleagues developed evidence-based recommendations on primary prevention of AD among pediatric patients and examined evidence of the association between AD and comorbidities. The workgroup developed 14 recommendations on primary prevention of AD, including a conditional recommendation for moisturizing skin care to decrease AD occurrence and conditional recommendations against early introduction of food, human milk consumption, and probiotic or vitamin D supplementation for primary prevention of AD. Although clinicians should be aware of comorbidities associated with pediatric AD, in order to optimize screening and/or management of comorbidities, further research is needed.
Dawn M.R. Davis, M.D., from the Mayo Clinic in Rochester, Minnesota, and colleagues developed evidence-based recommendations on the use of topical therapies, phototherapy, and systemic therapies for children and adolescents with AD. Twenty-seven evidence-based recommendations were developed on medical management of pediatric AD, including strong recommendations for moisturizers, topical calcineurin inhibitors, topical corticosteroids, crisaborole ointment, roflumilast cream, ruxolitinib cream, tapinarof cream, dupilumab, tralokinumab, lebrikizumab, nemolizumab with concomitant topical therapy, upadacitinib, abrocitinib, and baricitinib. Conditional recommendations were made in favor of bathing, bleach baths, wet dressings, phototherapy, methotrexate, mycophenolate mofetil, azathioprine, and cyclosporine.
"These guidelines were developed to educate and empower patients, caregivers, and the medical community so children with eczema receive the best care possible," Davis said in a statement. "Early, proactive intervention allows improvement in symptoms and quality of life for patients and their families."
Several authors from both studies disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-15 02:08
Read more
- ACC: Catheter-Directed Fibrinolysis Added to Anticoagulation Improves Pulmonary Embolism Outcomes
- Survey Shows More People Struggling To Afford ACA Insurance
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- New Rapid Urine Test Could Revolutionize Treatment of UTIs
- Low-Cost Platform Capable of Automated Anterior Segment Imaging for Eye Disease Screening
- Vascarta Announces Positive Clinical Trial Results for Topical/Transdermal Curcumin Gel VAS-101 in Knee Osteoarthritis
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions